company developing pharmaceuticals for animal health globally, thus strongly linked to agricultural business. Has ongoing increasing EPS, reasonable dividend which is covered by around 60% of profit, currently on aa dip. Despite China/us tensions, profit increased 10% given problems with Africa swine fever in China. Currently well valued. Potential keeper.
Gets my vote, love the sound of this one.